- Home
- ONCY vs STKS Comparison
ONCY vs STKS Comparison
Compare ONCY & STKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- STKS
- Stock Information
- Founded
- ONCY 1998
- STKS 2004
- Country
- ONCY Canada
- STKS United States
- Employees
- ONCY N/A
- STKS N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- STKS Restaurants
- Sector
- ONCY Health Care
- STKS Consumer Discretionary
- Exchange
- ONCY Nasdaq
- STKS Nasdaq
- Market Cap
- ONCY 89.7M
- STKS 77.7M
- IPO Year
- ONCY 1999
- STKS N/A
- Fundamental
- Price
- ONCY $1.11
- STKS $2.22
- Analyst Decision
- ONCY Strong Buy
- STKS Hold
- Analyst Count
- ONCY 5
- STKS 3
- Target Price
- ONCY $5.00
- STKS $4.50
- AVG Volume (30 Days)
- ONCY 900.3K
- STKS 65.9K
- Earning Date
- ONCY 11-07-2025
- STKS 11-03-2025
- Dividend Yield
- ONCY N/A
- STKS N/A
- EPS Growth
- ONCY N/A
- STKS N/A
- EPS
- ONCY N/A
- STKS N/A
- Revenue
- ONCY N/A
- STKS $834,363,000.00
- Revenue This Year
- ONCY N/A
- STKS $26.58
- Revenue Next Year
- ONCY N/A
- STKS $5.37
- P/E Ratio
- ONCY N/A
- STKS N/A
- Revenue Growth
- ONCY N/A
- STKS 96.64
- 52 Week Low
- ONCY $0.33
- STKS $2.25
- 52 Week High
- ONCY $1.51
- STKS $5.26
- Technical
- Relative Strength Index (RSI)
- ONCY 39.70
- STKS 34.44
- Support Level
- ONCY $1.16
- STKS $2.49
- Resistance Level
- ONCY $1.32
- STKS $2.64
- Average True Range (ATR)
- ONCY 0.07
- STKS 0.14
- MACD
- ONCY -0.01
- STKS -0.03
- Stochastic Oscillator
- ONCY 10.42
- STKS 6.84
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About STKS The ONE Group Hospitality Inc.
The One Group Hospitality Inc is a restaurant company that develops, owns and operates, manages and licenses upscale and polished casual, high-energy restaurants and lounges and provides turn-key food and beverage (F&B) services for hospitality venues, including hotels, casinos, and other high-end locations internationally. The company operates through four segments: STK, Benihana and Grill Concepts. The company generates the vast majority of its revenue from the domestic market.